Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide

Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxideElevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide, Published online: 20 February 2018; doi:10.1038/s41388-018-0139-xElevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide

Source: Oncogene - February 20, 2018 Category: Cancer & Oncology Authors: Huiyuan Zhang Qinyi Wang Junzhong Gu Le Yin Shenghui Liang Lida Wu Hao Xu Chao Zhao Yuchun Gu Source Type: research